ampelopsin has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dong, S; Hu, L; Jing, W; Lu, H; Wang, K; Wang, S; Zhao, X; Zhu, M | 1 |
1 other study(ies) available for ampelopsin and Colitis
Article | Year |
---|---|
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Bacteria; Bile Acids and Salts; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Dysbiosis; Fecal Microbiota Transplantation; Feces; Flavonols; Gastrointestinal Microbiome; Humans; Interleukin-1beta; Male; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 2021 |